<p>EHC = Endemic healthy controls (* a further 17 Colombian sera that were serologically negative with the lysate were included in the peptide ELISAs as additional controls); ND = not determined.</p>a<p>these 98 comprised 1 sample from each of 90 patients, plus 2 paired samples from each of 4 patients. All eight paired samples reacted with TSSApep-II/V/VI, and are included within the 67 Brazilian reactors to this peptide. 1 set of these pairs also reacted with TSSApep-V/VI.</p>b<p>same sample, which did not react with TSSApep-II/V/VI, TSSApep-V/VI or chimeras.</p>c<p>these 9 samples also reacted with chimera TSSA-II/-I peptide.</p>d<p>same sample, which did not react with TSSApep-II/V/VI, TSSApep-V/VI or chimeras.</p>e<p>same sample.</p>f...
BACKGROUND: Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a seri...
<p>Pools of sera (n = 10) from the different groups were depleted with peptide-1 (CT, control group;...
<p>Peptide names were abbreviated as follows: “6” denoting peptides from GRA6; “7” from GRA7; “I/III...
<p>Each data point represents the mean A<sub>490</sub> of the reaction of duplicates of each serum s...
<p>Lineage-specific peptides or lysate were added to rows of the ELISA plate as indicated. ELISA pla...
Peptide arrays comprising sets of fully overlapped 16mers and encompassing the complete sequence of ...
A) Arrays made up of consecutive 16mer peptides and spanning the complete sequences of TSSA referenc...
Background:Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a serio...
ELISA was performed in different groups of individuals. Groups negative for VL (white circle): contr...
Peptide arrays comprising sets of fully overlapped 15mers, spanning residues 30 to 55 of TSSAII refe...
<p>Reactivity of peptide C6_30_cons against the sera from mice infected with Colombiana (A), Y (B), ...
<p>Sera (A–C) and plasma (D–I) samples obtained in year 2010 (A–F) and year 2009 (G–I) from voluntee...
Background: Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a seri...
An enzyme-linked immunosorbent assay (ELISA) has been developed to detect antibodies in human sera t...
<p>Immunoreactivity against the 12 selected peptides was determined in a set of 21 <i>O</i>. <i>volv...
BACKGROUND: Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a seri...
<p>Pools of sera (n = 10) from the different groups were depleted with peptide-1 (CT, control group;...
<p>Peptide names were abbreviated as follows: “6” denoting peptides from GRA6; “7” from GRA7; “I/III...
<p>Each data point represents the mean A<sub>490</sub> of the reaction of duplicates of each serum s...
<p>Lineage-specific peptides or lysate were added to rows of the ELISA plate as indicated. ELISA pla...
Peptide arrays comprising sets of fully overlapped 16mers and encompassing the complete sequence of ...
A) Arrays made up of consecutive 16mer peptides and spanning the complete sequences of TSSA referenc...
Background:Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a serio...
ELISA was performed in different groups of individuals. Groups negative for VL (white circle): contr...
Peptide arrays comprising sets of fully overlapped 15mers, spanning residues 30 to 55 of TSSAII refe...
<p>Reactivity of peptide C6_30_cons against the sera from mice infected with Colombiana (A), Y (B), ...
<p>Sera (A–C) and plasma (D–I) samples obtained in year 2010 (A–F) and year 2009 (G–I) from voluntee...
Background: Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a seri...
An enzyme-linked immunosorbent assay (ELISA) has been developed to detect antibodies in human sera t...
<p>Immunoreactivity against the 12 selected peptides was determined in a set of 21 <i>O</i>. <i>volv...
BACKGROUND: Chagas disease, caused by infection with the protozoan Trypanosoma cruzi, remains a seri...
<p>Pools of sera (n = 10) from the different groups were depleted with peptide-1 (CT, control group;...
<p>Peptide names were abbreviated as follows: “6” denoting peptides from GRA6; “7” from GRA7; “I/III...